| The gene variations included in the Cardiovascular Genescreen are important contributing factors to dyslipidaemia, thrombophilia, or altered nutrient requirements that may lead to abnormal blood levels (e.g. homocysteine, serum iron status) in the presence of (modifiable) environmental triggers. This test is performed in conjunction with a medical and lifestyle assessment to determine gene expression as reflected by biochemical abnormalities that in turn could be used to monitor response to treatment. This multi-gene test enables diagnosis of CVD subtypes that require different treatment strategies for effective intervention. It improves diagnostic reliability and defines the clinical, biochemical, genetic and environmental risk components as contributing factors to CVD risk. |  | |